543 related articles for article (PubMed ID: 26858407)
1. Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses.
Li Y; Banerjee S; Wang Y; Goldstein SA; Dong B; Gaughan C; Silverman RH; Weiss SR
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2241-6. PubMed ID: 26858407
[TBL] [Abstract][Full Text] [Related]
2. Activation of RNase L in Egyptian Rousette Bat-Derived RoNi/7 Cells Is Dependent Primarily on OAS3 and Independent of MAVS Signaling.
Li Y; Dong B; Wei Z; Silverman RH; Weiss SR
mBio; 2019 Nov; 10(6):. PubMed ID: 31719180
[TBL] [Abstract][Full Text] [Related]
3. OAS1 and OAS3 negatively regulate the expression of chemokines and interferon-responsive genes in human macrophages.
Lee WB; Choi WY; Lee DH; Shim H; Kim-Ha J; Kim YJ
BMB Rep; 2019 Feb; 52(2):133-138. PubMed ID: 30078389
[TBL] [Abstract][Full Text] [Related]
4. Distinct antiviral roles for human 2',5'-oligoadenylate synthetase family members against dengue virus infection.
Lin RJ; Yu HP; Chang BL; Tang WC; Liao CL; Lin YL
J Immunol; 2009 Dec; 183(12):8035-43. PubMed ID: 19923450
[TBL] [Abstract][Full Text] [Related]
5. The 2'-5'-oligoadenylate synthetase 3 enzyme potently synthesizes the 2'-5'-oligoadenylates required for RNase L activation.
Ibsen MS; Gad HH; Thavachelvam K; Boesen T; Desprès P; Hartmann R
J Virol; 2014 Dec; 88(24):14222-31. PubMed ID: 25275129
[TBL] [Abstract][Full Text] [Related]
6. Zika Virus Production Is Resistant to RNase L Antiviral Activity.
Whelan JN; Li Y; Silverman RH; Weiss SR
J Virol; 2019 Aug; 93(16):. PubMed ID: 31142667
[TBL] [Abstract][Full Text] [Related]
7. Condensation of RNase L promotes its rapid activation in response to viral infection in mammalian cells.
Cusic R; Burke JM
Sci Signal; 2024 May; 17(837):eadi9844. PubMed ID: 38771918
[TBL] [Abstract][Full Text] [Related]
8. The ribonuclease L-dependent antiviral roles of human 2',5'-oligoadenylate synthetase family members against hepatitis C virus.
Kwon YC; Kang JI; Hwang SB; Ahn BY
FEBS Lett; 2013 Jan; 587(2):156-64. PubMed ID: 23196181
[TBL] [Abstract][Full Text] [Related]
9. Cell-type-specific effects of RNase L on viral induction of beta interferon.
Banerjee S; Chakrabarti A; Jha BK; Weiss SR; Silverman RH
mBio; 2014 Feb; 5(2):e00856-14. PubMed ID: 24570368
[TBL] [Abstract][Full Text] [Related]
10. Opposing Roles of Double-Stranded RNA Effector Pathways and Viral Defense Proteins Revealed with CRISPR-Cas9 Knockout Cell Lines and Vaccinia Virus Mutants.
Liu R; Moss B
J Virol; 2016 Sep; 90(17):7864-79. PubMed ID: 27334583
[TBL] [Abstract][Full Text] [Related]
11. The role of mouse 2',5'-oligoadenylate synthetase 1 paralogs.
Elkhateeb E; Tag-El-Din-Hassan HT; Sasaki N; Torigoe D; Morimatsu M; Agui T
Infect Genet Evol; 2016 Nov; 45():393-401. PubMed ID: 27663720
[TBL] [Abstract][Full Text] [Related]
12. Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon.
Birdwell LD; Zalinger ZB; Li Y; Wright PW; Elliott R; Rose KM; Silverman RH; Weiss SR
J Virol; 2016 Jan; 90(6):3160-72. PubMed ID: 26739051
[TBL] [Abstract][Full Text] [Related]
13. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme.
Rivas C; Gil J; Mĕlková Z; Esteban M; Díaz-Guerra M
Virology; 1998 Apr; 243(2):406-14. PubMed ID: 9568039
[TBL] [Abstract][Full Text] [Related]
14. Activation of the 2-5OAS/RNase L pathway in CVB1 or HAV/18f infected FRhK-4 cells does not require induction of OAS1 or OAS2 expression.
Kulka M; Calvo MS; Ngo DT; Wales SQ; Goswami BB
Virology; 2009 May; 388(1):169-84. PubMed ID: 19383565
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the OAS/RNase L pathway by viruses.
Drappier M; Michiels T
Curr Opin Virol; 2015 Dec; 15():19-26. PubMed ID: 26231767
[TBL] [Abstract][Full Text] [Related]
16. Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication.
Díaz-Guerra M; Rivas C; Esteban M
Virology; 1997 Jan; 227(1):220-8. PubMed ID: 9007077
[TBL] [Abstract][Full Text] [Related]
17. RNase L plays a role in the antiviral response to West Nile virus.
Scherbik SV; Paranjape JM; Stockman BM; Silverman RH; Brinton MA
J Virol; 2006 Mar; 80(6):2987-99. PubMed ID: 16501108
[TBL] [Abstract][Full Text] [Related]
18. RNase L Antiviral Activity Is Not a Critical Component of the Oas1b-Mediated Flavivirus Resistance Phenotype.
Madden JC; Cui D; Brinton MA
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462564
[TBL] [Abstract][Full Text] [Related]
19. New insights into the role of RNase L in innate immunity.
Chakrabarti A; Jha BK; Silverman RH
J Interferon Cytokine Res; 2011 Jan; 31(1):49-57. PubMed ID: 21190483
[TBL] [Abstract][Full Text] [Related]
20. A human cellular noncoding RNA activates the antiviral protein 2'-5'-oligoadenylate synthetase 1.
Calderon BM; Conn GL
J Biol Chem; 2018 Oct; 293(41):16115-16124. PubMed ID: 30126839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
